Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Context: The diagnosis of familial hypercholesterolemia (FH) can be made using the Dutch Lipid Clinic Network criteria. This employs the personal and family history of premature coronary artery disease and hypercholesterolemia and the presence of a pathogenic mutation in the low-density lipoprotein receptor (LDLR) and apolipoprotein B (APOB) genes. Objective: We employed this tool to investigate the prevalence of FH and the associations between FH and coronary artery disease and cholesterol-lowering medication in the Copenhagen General Population Study. Setting: The study was of an unselected, community-based population comprising 69,016 participants. Main Outcome Measures: FH (definite/probable) was defined as a Dutch Lipid Clinic Network score higher than 5. Coronary artery disease was myocardial infarction or angina pectoris. Results: The prevalence of FH was 0.73% (one in 137). Of participants with FH, 20% had an LDLR or APOB mutation. The prevalence of coronary artery disease among FH participants was 33%. Only 48% of subjects with FH admitted to taking cholesterol-lowering medication. The odds ratio for coronary artery disease off cholesterol-lowering medication was 13.2 (10.0–17.4) in definite/probable FH compared with non-FH subjects, after adjusting for age, gender, body mass index, hypertension, metabolic syndrome and diabetes, and smoking. The corresponding adjusted odds ratio for coronary artery disease in FH subjects on cholesterol-lowering medication was 10.3 (7.8–13.8). Conclusion: The prevalence of FH appears to be higher than commonly perceived in a general population of white Danish individuals, with at least half of affected subjects not receiving cholesterol-lowering medication. The very high risk of coronary artery disease irrespective of use of medication reflects the extent of underdiagnosis and undertreatment of FH in the community and primary care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The frequency of HeFH in the population has earlier been estimated at 1/500; however, recent studies from whole populations suggest that the frequency is higher, in some populations as high as 1/137. 297”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [297]
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
(2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00002 · Cited by 2,672
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Self-citationJones, P. H., Davidson, M. H., Stein, E. A., Bays, H. E., McKenney, J. M., Miller, E., Cain, V. A., & Blasetto, J. W. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00530-7 · Cited by 1,398
Genetically elevated C-reactive protein and ischemic vascular disease
Zacho, J., Tybjærg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., & Nordestgaard, B. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707402 · Cited by 839
Self-citationKotseva, K., Wood, D., Backer, G. D., Bacquer, D. D., Pyörälä, K., Keil, U., & EUROASPIRE Study Group (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283294b1d · Cited by 812
Efficacy of statins in familial hypercholesterolaemia: a long term cohort study
Versmissen, J., Oosterveer, D. M., Yazdanpanah, M., Defesche, J. C., Basart, D. C. G., Liem, A. H., Heeringa, J., Witteman, J. C., Lansberg, P. J., Kastelein, J. J. P., et al. (2008) · BMJ · doi:10.1136/bmj.a2423 · Cited by 721
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
Research works printed but not linked: 1
- World Health Organization, 1999, Familial hypercholesterolaemia (FH)
Cited by
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
Nordestgaard, B. G., Chapman, M. J., Humphries, S. E., Ginsberg, H. N., Masana, L., Descamps, O. S., Wiklund, O., Hegele, R. A., Raal, F. J., Defesche, J. C., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht273 · Cited by 2,761
Self-citation2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582
Epidemiology of cardiovascular disease in young individuals
Andersson, C., & Vasan, R. S. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.154 · Cited by 714
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
ATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017
Faludi, A., Izar, M., Saraiva, J., Chacra, A., Bianco, H., Afiune Neto, A., Bertolami, A., Pereira, A., Lottenberg, A., Sposito, A., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170121 · Cited by 633
Worldwide Prevalence of Familial Hypercholesterolemia
Beheshti, S. O., Madsen, C. M., Varbo, A., & Nordestgaard, B. G. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.057 · Cited by 625
Self-citationClinical Genetic Testing for Familial Hypercholesterolemia
Sturm, A. C., Knowles, J. W., Gidding, S. S., Ahmad, Z. S., Ahmed, C. D., Ballantyne, C. M., Baum, S. J., Bourbon, M., Carrié, A., Cuchel, M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.044 · Cited by 615
Self-citationTalmud, P. J., Shah, S., Whittall, R., Futema, M., Howard, P., Cooper, J. A., Harrison, S. C., Li, K., Drenos, F., Karpe, F., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62127-8 · Cited by 591
Nordestgaard, B. G., & Langsted, A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r071233 · Cited by 575
Self-citationHu, P., Dharmayat, K. I., Stevens, C. A. T., Sharabiani, M. T. A., Jones, R. S., Watts, G. F., Genest, J., Ray, K. K., & Vallejo-Vaz, A. J. (2020) · Circulation · doi:10.1161/circulationaha.119.044795 · Cited by 553
Self-citationFamilial hypercholesterolaemia
Defesche, J. C., Gidding, S. S., Harada-Shiba, M., Hegele, R. A., Santos, R. D., & Wierzbicki, A. S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.93 · Cited by 453
de Ferranti, S. D., Steinberger, J., Ameduri, R., Baker, A., Gooding, H., Kelly, A. S., Mietus-Snyder, M., Mitsnefes, M. M., Peterson, A. L., St-Pierre, J., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000618 · Cited by 441
Sjouke, B., Kusters, D. M., Kindt, I., Besseling, J., Defesche, J. C., Sijbrands, E. J. G., Roeters van Lennep, J. E., Stalenhoef, A. F. H., Wiegman, A., de Graaf, J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu058 · Cited by 443
Genetic identification of familial hypercholesterolemia within a single U.S. health care system
Abul-Husn, N. S., Manickam, K., Jones, L. K., Wright, E. A., Hartzel, D. N., Gonzaga-Jauregui, C., O’Dushlaine, C., Leader, J. B., Lester Kirchner, H., Lindbuchler, D. M., et al. (2016) · Science · doi:10.1126/science.aaf7000 · Cited by 425
Santos, R. D., Gidding, S. S., Hegele, R. A., Cuchel, M. A., Barter, P. J., Watts, G. F., Baum, S. J., Catapano, A. L., Chapman, M. J., Defesche, J. C., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30041-9 · Cited by 419
Self-citationBenn, M., Watts, G. F., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw028 · Cited by 400
Self-citationde Ferranti, S. D., Rodday, A. M., Mendelson, M. M., Wong, J. B., Leslie, L. K., & Sheldrick, R. C. (2016) · Circulation · doi:10.1161/circulationaha.115.018791 · Cited by 380
“We used adapted DLC criteria(2) in our main analysis of adults because they were the most appropriate for use in a general population.(3,7) Other published FH definitions include the Make Early Diagnosis to Prevent Early Deaths (MEDPED) definition,(19) which is designed primarily for cascade screening, and the Simon B…”
MethodResultInfluentialAkioyamen, L. E., Genest, J., Shan, S. D., Reel, R. L., Albaum, J. M., Chu, A., & Tu, J. V. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016461 · Cited by 344
Pérez de Isla, L., Alonso, R., Mata, N., Fernández-Pérez, C., Muñiz, O., Díaz-Díaz, J. L., Saltijeral, A., Fuentes-Jiménez, F., de Andrés, R., Zambón, D., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024541 · Cited by 342
Self-citationChild–Parent Familial Hypercholesterolemia Screening in Primary Care
Wald, D. S., Bestwick, J. P., Morris, J. K., Whyte, K., Jenkins, L., & Wald, N. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602777 · Cited by 320
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., de Ferranti, S. D., et al. (2026) · JACC · doi:10.1016/j.jacc.2025.11.016 · Cited by 304
The complex molecular genetics of familial hypercholesterolaemia
Berberich, A. J., & Hegele, R. A. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0052-6 · Cited by 290
Langsted, A., Kamstrup, P. R., Benn, M., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30042-0 · Cited by 270
Self-citationShiu, E. Y. C., Leung, N. H. L., & Cowling, B. J. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000563 · Cited by 235
Vallejo-Vaz, A. J., De Marco, M., Stevens, C. A. T., Akram, A., Freiberger, T., Hovingh, G. K., Kastelein, J. J. P., Mata, P., Raal, F. J., Santos, R. D., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.08.051 · Cited by 231
Self-citationdeGoma, E. M., Ahmad, Z. S., O’Brien, E. C., Kindt, I., Shrader, P., Newman, C. B., Pokharel, Y., Baum, S. J., Hemphill, L. C., Hudgins, L. C., et al. (2016) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.116.001381 · Cited by 224
Futema, M., Shah, S., Cooper, J. A., Li, K., Whittall, R. A., Sharifi, M., Goldberg, O., Drogari, E., Mollaki, V., Wiegman, A., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.231365 · Cited by 213
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
Schmidt, A. F., Pearce, L. S., Wilkins, J. T., Overington, J. P., Hingorani, A. D., & Casas, J. P. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011748.pub2 · Cited by 205
Landmesser, U., Chapman, M. J., Stock, J. K., Amarenco, P., Belch, J. J. F., Borén, J., Farnier, M., Ference, B. A., Gielen, S., Graham, I., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx549 · Cited by 200
Perak, A. M., Ning, H., de Ferranti, S. D., Gooding, H. C., Wilkins, J. T., & Lloyd-Jones, D. M. (2016) · Circulation · doi:10.1161/circulationaha.116.022335 · Cited by 198
Familial Hypercholesterolemia—Epidemiology, Diagnosis, and Screening
Singh, S., & Bittner, V. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0482-5 · Cited by 195
Familial hypercholesterolaemia: A global call to arms
Vallejo-Vaz, A. J., Kondapally Seshasai, S. R., Cole, D., Hovingh, G. K., Kastelein, J. J. P., Mata, P., Raal, F. J., Santos, R. D., Soran, H., Watts, G. F., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.09.021 · Cited by 178
Self-citationAPOE gene variants in primary dyslipidemia
Khalil, Y. A., Rabès, J.-P., Boileau, C., & Varret, M. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.05.007 · Cited by 170
Bekkering, S., Stiekema, L. C. A., Bernelot Moens, S., Verweij, S. L., Novakovic, B., Prange, K., Versloot, M., Roeters van Lennep, J. E., Stunnenberg, H., de Winther, M., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.014 · Cited by 167
Statins in Familial Hypercholesterolemia
Besseling, J., Hovingh, G. K., Huijgen, R., Kastelein, J. J. P., & Hutten, B. A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.04.054 · Cited by 167
Pérez de Isla, L., Alonso, R., Mata, N., Saltijeral, A., Muñiz, O., Rubio-Marin, P., Diaz-Diaz, J. L., Fuentes, F., de Andrés, R., Zambón, D., et al. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.307514 · Cited by 162
Bucholz, E. M., Rodday, A. M., Kolor, K., Khoury, M. J., & de Ferranti, S. D. (2018) · Circulation · doi:10.1161/circulationaha.117.032321 · Cited by 160
Universal Screening for Familial Hypercholesterolemia in Children
Klančar, G., Grošelj, U., Kovač, J., Bratanič, N., Bratina, N., Podkrajšek, K. T., & Battelino, T. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.017 · Cited by 158
Miname, M. H., Bittencourt, M. S., de Moraes, S. R., Alves, R. I. M., Silva, P. R. S., Jannes, C. E., Pereira, A. C., Krieger, J. E., Nasir, K., & Santos, R. D. (2018) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.09.019 · Cited by 158
Backer, G. D., Besseling, J., Chapman, J., Hovingh, G. K., Kastelein, J. J. P., Kotseva, K., Ray, K. K., Reiner, Ž., Wood, D., & Bacquer, D. D. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.809 · Cited by 155
Nanchen, D., Gencer, B., Auer, R., Räber, L., Stefanini, G. G., Klingenberg, R., Schmied, C. M., Cornuz, J., Müller, O., Vogt, P., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv289 · Cited by 153
Fogacci, F., Ferri, N., Toth, P. P., Ruscica, M., Corsini, A., & Cicero, A. F. G. (2019) · Drugs · doi:10.1007/s40265-019-01114-z · Cited by 132
Haralambos, K., Whatley, S. D., Edwards, R. M., Gingell, R., Townsend, D., Ashfield-Watt, P. A. L., Lansberg, P. J., Datta, D. B. N., & McDowell, I. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.03.003 · Cited by 150
Mundal, L. J., Sarancic, M., Ose, L., Iversen, P. O., Borgan, J., Veierød, M. B., Leren, T. P., & Retterstøl, K. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001236 · Cited by 139
Bouhairie, V. E., & Goldberg, A. C. (2015) · Cardiology Clinics · doi:10.1016/j.ccl.2015.01.001 · Cited by 178
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
Schmidt, A. F., Carter, J.-P. L., Pearce, L. S., Wilkins, J. T., Overington, J. P., Hingorani, A. D., & Casas, J. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011748.pub3 · Cited by 123
Kerr, M., Pears, R., Miedzybrodzka, Z., Haralambos, K., Cather, M., Watson, M., & Humphries, S. E. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx111 · Cited by 130
Writing Committee Members, Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001423 · Cited by 122
Toward an international consensus—Integrating lipoprotein apheresis and new lipid-lowering drugs
Stefanutti, C., Julius, U., Watts, G. F., Harada‐Shiba, M., Cossu, M., Schettler, V. J. J., Silvestro, G. D., Soran, H., van Lennep, J. E. R., Pisciotta, L., et al. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.04.114 · Cited by 122
Self-citationPrognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes
Nanchen, D., Gencer, B., Müller, O., Auer, R., Aghlmandi, S., Heg, D., Klingenberg, R., Räber, L., Carballo, D., Carballo, S., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.023007 · Cited by 126
Genetics of Familial Hypercholesterolemia: New Insights
Vrablík, M., Tichý, L., Freiberger, T., Blaha, V., Satny, M., & Hubacek, J. A. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.574474 · Cited by 135
Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia
Genest, J. J., Hegele, R. A., Bergeron, J., Brophy, J. M., Carpentier, A. C., Couture, P., Davignon, J., Dufour, R., Frohlich, J. J., Gaudet, D., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.09.028 · Cited by 119
Vallejo‐Vaz, A. J., Akram, A., Seshasai, S. R. K., Cole, D., Watts, G. F., Hovingh, G. K., Kastelein, J. J. P., Mata, P., Raal, F. J., Santos, R. D., et al. (2016) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2016.10.001 · Cited by 122
Self-citationWang, A., Richhariya, A., Gandra, S. R., Calimlim, B., Kim, L., Quek, R. G. W., Nordyke, R. J., & Toth, P. P. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003294 · Cited by 115
Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction
Singh, A., Gupta, A., Collins, B., Qamar, A., Monda, K. L., Biery, D. W., López, J. A. G., de Ferranti, S. D., Plutzky, J., Cannon, C. P., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.059 · Cited by 128
Management of patients with familial hypercholesterolaemia
Reiner, Ž. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.92 · Cited by 115
Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects
Jannes, C. E., Santos, R. D., Silva, P. R. S., Turolla, L., Gagliardi, A. C. M., Marsiglia, J. D. C., Chacra, A. P. M., Miname, M. H., Rocha, V. Z., Filho, W. S., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.11.009 · Cited by 109
Shi, Z., Yuan, B., Zhao, D. H., Taylor, A. W., Lin, J., & Watts, G. F. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.165 · Cited by 103
Self-citationPatel, A. P., Wang, M., Fahed, A. C., Mason‐Suares, H., Brockman, D., Pelletier, R. C., Amr, S. S., Machini, K., Hawley, M. H., Witkowski, L., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.3959 · Cited by 108
Safarova, M. S., Liu, H., & Kullo, I. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.08.001 · Cited by 107
France, M. W., Rees, A., Datta, D. B. N., Thompson, G. R., Capps, N. E., Ferns, G. A., Ramaswami, U., Seed, M., Neely, D., Cramb, R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.017 · Cited by 107
Jacobs, J. A., Addo, D. K., Zheutlin, A. R., Derington, C. G., Essien, U. R., Navar, A. M., Hernandez, I., Lloyd-Jones, D. M., King, J. B., Rao, S., et al. (2023) · JAMA Cardiology · doi:10.1001/jamacardio.2023.0228 · Cited by 97
The New Pooled Cohort Equations Risk Calculator
Preiss, D., & Kristensen, S. L. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.001 · Cited by 102
Wong, B. J. O., Kruse, G. B., Kutikova, L., Ray, K. K., Mata, P., & Bruckert, É. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.05.006 · Cited by 95
Vuorio, A. F., Docherty, K. F., Humphries, S. E., Kuoppala, J., & Kovanen, P. T. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.10.032 · Cited by 97
Krogh, H. W., Mundal, L. J., Holven, K. B., & Retterstøl, K. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv602 · Cited by 91
Brænne, I., Kleinecke, M., Reiz, B., Graf, E., Strom, T. M., Wieland, T., Fischer, M., Kessler, T., Hengstenberg, C., Meitinger, T., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.100 · Cited by 94
Gandra, S. R., Villa, G., Fonarow, G. C., Löthgren, M., Lindgren, P., Somaratne, R. M., & van Hout, B. (2016) · Clinical Cardiology · doi:10.1002/clc.22535 · Cited by 95
Cascade screening for familial hypercholesterolemia: Practical consequences
Louter, L., Defesche, J. C., & van Lennep, J. E. R. (2017) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2017.05.019 · Cited by 85
Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels
Bianconi, V., Banach, M., & Pirro, M. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.03.004 · Cited by 100
Pang, J., Poulter, E. B., Bell, D. A., Bates, T. R., Jefferson, V.-L., Hillis, G. S., Schultz, C. J., & Watts, G. F. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.07.005 · Cited by 84
Self-citationNordestgaard, B. G., & Benn, M. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx136 · Cited by 91
Self-citationSignificance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease
Li, S., Wu, N., Zhu, C., Zhang, Y., Guo, Y., Gao, Y., Li, X., Qing, P., Cui, C.-J., Xu, R., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.03.021 · Cited by 82
McKay, A. J., Hogan, H., Humphries, S. E., Marks, D., Ray, K. K., & Miners, A. H. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.05.047 · Cited by 84
Lomitapide: a review of its clinical use, efficacy, and tolerability
Alonso, R., Cuevas, A., & Mata, P. (2019) · Core Evidence · doi:10.2147/ce.s174169 · Cited by 81
Akioyamen, L. E., Genest, J. J., Chu, A., Inibhunu, H., Ko, D. T., & Tu, J. V. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.10.012 · Cited by 88
Familial Hypercholesterolemia: a Review of the Natural History, Diagnosis, and Management
Najam, O., & Ray, K. K. (2015) · Cardiology and Therapy · doi:10.1007/s40119-015-0037-z · Cited by 98
Sharifi, M., Higginson, E. J., Bos, S., Gallivan, A., Harvey, D., Li, K., Abeysekera, A., Haddon, A., Ashby, H. L., Shipman, K. E., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.05.015 · Cited by 82
Beheshti, S. O., Madsen, C. M., Varbo, A., Benn, M., & Nordestgaard, B. G. (2018) · Circulation · doi:10.1161/circulationaha.118.033470 · Cited by 83
Self-citationDathan-Stumpf, A., Vogel, M., Hiemisch, A., Thiery, J., Burkhardt, R., Kratzsch, J., & Kiess, W. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.02.010 · Cited by 75
Prevalence and treatment of familial hypercholesterolaemia in Australian communities
Watts, G. F., Shaw, J. E., Pang, J., Magliano, D. J., Jennings, G., & Carrington, M. J. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.027 · Cited by 75
Self-citationFamilial hypercholesterolemia: Review of diagnosis, screening, and treatment.
Turgeon, R. D., Barry, A. R., & Pearson, G. J. (2016) · Canadian Family Physician · Cited by 79
Cardiovascular risk stratification in familial hypercholesterolaemia
Sharifi, M., Rakhit, R. D., Humphries, S. E., & Nair, D. R. (2016) · Heart · doi:10.1136/heartjnl-2015-308845 · Cited by 82
Casula, M., Olmastroni, E., Pirillo, A., Catapano, A. L., Arca, M., Averna, M., Bertolini, S., Calandra, S., Catapano, A. L., Tarugi, P., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.08.013 · Cited by 77
Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype–Genotype Relationship
Sánchez-Hernández, R. M., Civeira, F., Stef, M. A., Pérez‐Calahorra, S., Almagro, F., Plana, N., Novoa, F. J., de Aranzubía, P. S., Mosquera, D., Soler, C., et al. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.116.001545 · Cited by 83
Bourbon, M., Alves, A. C., Rodrigo Alonso, K., Mata, N., Aguiar, P. M. V., Padró, T., & Mata, P. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.04.002 · Cited by 80
Bell, D. A., Pang, J., Burrows, S., Bates, T. R., BOCKXMEER, F. M. V., Hooper, A. J., O'Leary, P. C., Burnett, J. R., & Watts, G. F. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.036 · Cited by 81
Self-citationKlose, G., Laufs, U., März, W., & Windler, E. E. T. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0523 · Cited by 88
Familial Hypercholesterolemia Phenotype in Chinese Patients Undergoing Coronary Angiography
Li, J., Li, S., Zhu, C., Wu, N., Zhang, Y., Guo, Y., Gao, Y., Li, X., Qing, P., Cui, C.-J., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308456 · Cited by 70
Zamora, A., Masana, L., Comas‐Cufí, M., Vila, À., Plana, N., García-Gil, M., Alves‐Cabratosa, L., Marrugat, J., Degano, I. R., & Ramos, R. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.05.012 · Cited by 80
Masana, L., Zamora, A., Plana, N., Comas‐Cufí, M., García-Gil, M., Martí‐Lluch, R., Ponjoan, A., Alves‐Cabratosa, L., Elosúa, R., Marrugat, J., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071080 · Cited by 75
Mundal, L. J., Igland, J., Veierød, M. B., Holven, K. B., Ose, L., Selmer, R. M., Wisløff, T. F., Kristiansen, I. S., Tell, G. S., Leren, T. P., et al. (2018) · Heart · doi:10.1136/heartjnl-2017-312706 · Cited by 74
Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney Disease
Emanuelsson, F., Nordestgaard, B. G., & Benn, M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01058 · Cited by 66
Self-citationKastelein, J. J. P., Hovingh, G. K., Langslet, G., Baccara‐Dinet, M. T., Gipe, D. A., Chaudhari, U., Zhao, J. M., Minini, P., & Farnier, M. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.12.004 · Cited by 70
Bell, D. A., Garton‐Smith, J., Vickery, A. W., Kirke, A. B., Pang, J., Bates, T. R., & Watts, G. F. (2013) · Heart Lung and Circulation · doi:10.1016/j.hlc.2013.08.005 · Cited by 65
Self-citationHarada‐Shiba, M., Ako, J., Arai, H., Hirayama, A., Murakami, Y., Nohara, A., Ozaki, A., Uno, K., & Nakamura, M. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.856 · Cited by 64
Sjouke, B., Hovingh, G. K., Kastelein, J. J. P., & Stefanutti, C. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000179 · Cited by 67
Pećin, I., Hartgers, M. L., Hovingh, G. K., Dent, R. E., & Reiner, Ž. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317717346 · Cited by 70
Reducing the burden of disease and death from familial hypercholesterolemia: A call to action
Knowles, J. W., O'Brien, E. C., Greendale, K., Wilemon, K. A., Genest, J. J., Sperling, L. S., Neal, W. A., Rader, D. J., & Khoury, M. J. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.09.001 · Cited by 63
Metadata
- Authors
- Benn, M., Watts, G. F., Tybjaerg-Hansen, A., & Nordestgaard, B. G.
- Affiliations
- University of Copenhagen (DK)
- The University of Western Australia (AU)
- The Copenhagen General Population Study (M.B., A.T.-H., B.G.N.), Herlev Hospital, Copenhagen University Hospital, DK-2730 Herlev, Denmark
- Corresponding author
- Nordestgaard, Børge G.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-11-01
- Volume
- 97
- Issue
- 11
- Pages
- 3956-3964
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1993634977
- Cited by
- 632
- References
- 38
- Citations by year
- 2026: 28 · 2025: 23 · 2024: 28 · 2023: 37 · 2022: 42 · 2021: 36 · 2020: 44 · 2019: 48 · 2018: 61 · 2017: 80 · 2016: 92 · 2015: 53 · 2014: 42 · 2013: 15 · 2012: 1
- FWCI
- 36.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Funders
- Amgen
- Pfizer
- AstraZeneca
- Sanofi
- Sundhed og Sygdom, Det Frie Forskningsråd
- Regeneron Pharmaceuticals
- Gentofte Hospital
- Herlev Hospital
- Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- familial hypercholesterolemia, prevalence, coronary artery disease, cholesterol-lowering drugs, LDLR mutations, APOB mutations, Dutch Lipid Clinic Network criteria, underdiagnosis, undertreatment, myocardial infarction, angina pectoris, Copenhagen General Population Study
- MeSH terms
- Aged, Anticholesteremic Agents, Coronary Artery Disease, Denmark, Female, Genotype, Humans, Hyperlipoproteinemia Type II, Lipids, Lipoproteins, Male, Middle Aged, Risk, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.